Spur Therapeutics

📍 Stevenage, United Kingdom🗓 Founded 2015👥 329 employees💰 Last funded Mar 2024
Biotechnology Research🌐 spurtherapeutics.com
Website LinkedIn
Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results. Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine. Toward life-changing therapies, and brighter futures. Toward More™
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Spur Therapeutics?
Spur Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Spur Therapeutics last raise funding?
The most recent investment in Spur Therapeutics recorded on gritt.io was in March 2024.
When was Spur Therapeutics founded?
Spur Therapeutics was founded in 2015.
What industry is Spur Therapeutics in?
Spur Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Spur Therapeutics based?
Spur Therapeutics is headquartered in Stevenage, United Kingdom.